No single pain-relief method stands out as universally best for abdominal adhesions, because the pain itself is unpredictable and the condition responds differently depending on how severe the adhesions are, where they sit, and whether they are causing mechanical problems like bowel kinks or primarily triggering nerve-related pain. What works in practice is usually a stepwise approach: starting with the least invasive options, escalating if needed, and combining strategies. The challenge is that adhesion pain has been historically undertreated and understudied, leaving patients and clinicians with fewer high-quality trials to guide decisions than you would find for most other chronic pain conditions.
Why Adhesions Cause Pain in the First Place
Adhesions are bands of scar tissue that form between abdominal organs and the inner wall of the abdomen, most often after surgery. After a surgical incision heals, the body deposits fibrin to patch the wounded peritoneum. If that fibrin is not fully broken down within roughly five to seven days, fibroblasts colonize it and begin laying down collagen, eventually forming a permanent band of scar tissue with its own blood supply.1Asian Journal of Surgery. Current options for the prevention of postoperative intra-abdominal adhesions That process is common: adhesions develop in anywhere from 20 to 90 percent of patients after gynecologic or abdominal procedures, depending on the type of surgery.2PubMed Central. Gynecologic postoperative anti-adhesion barriers: From biomaterials to barrier development
Not everyone with adhesions experiences pain, and for a long time surgeons debated whether the bands themselves could even generate painful signals. That question has been largely settled. Researchers have found sensory nerve fibers in adhesion tissue regardless of the adhesion’s size, location, or estimated age, including fibers containing substance P and CGRP, two molecules associated with pain signaling.3PubMed Central. Presence and Distribution of Sensory Nerve Fibers in Human Peritoneal Adhesions More recent work has shown that adhesions from patients who report chronic pain contain significantly more nerve tissue than adhesions from patients without pain, and that nerve growth factor (NGF) expression is higher in the painful group.4PubMed Central. Morphological features and molecular mechanisms in peritoneal adhesions from patients with chronic abdominal postoperative pain In other words, adhesions are not just inert scar tissue. They are biologically active structures with their own nerve supply, and some adhesions appear to be wired for pain more than others.
Pain can also come from traction: when adhesion bands pull on the bowel or other organs during movement, eating, or even breathing, they create intermittent tugging sensations that range from a dull ache to sharp cramping. This mechanical component is partly why adhesion pain is so variable from person to person and from day to day.
Medications for Adhesion Pain
Standard over-the-counter painkillers like ibuprofen or acetaminophen are usually the first line. They can take the edge off mild to moderate discomfort, and anti-inflammatory drugs may help when adhesions trigger localized inflammation. But these medications are not specifically designed for adhesion-related pain, and many patients find they provide only partial relief.
The most studied prescription option specifically tested for adhesion pain is pregabalin, a drug originally approved for nerve pain conditions. In a small randomized trial of patients with confirmed abdominal adhesion pain, pregabalin significantly reduced patient-documented pain scores compared with placebo during the blinded phase of the study.5PubMed. Pregabalin for the treatment of abdominal adhesion pain: a randomized, double-blind, placebo-controlled trial A later systematic review of analgesic treatments for adhesion-related chronic abdominal pain noted that pregabalin tended to benefit patients over placebo at three months, though the trial was small.6PubMed. Analgesia in patients with adhesion-related chronic abdominal and pelvic pain after surgery: a systematic review The fact that a nerve-pain drug shows promise makes sense given the nerve fibers found in adhesion tissue, but this remains an area where larger trials are needed before pregabalin can be called a definitive treatment. Its side effects, including drowsiness and dizziness, also limit its usefulness for some people.
Opioid painkillers sometimes enter the picture for severe cases, but they carry well-known risks of dependence and can worsen gut motility, which is already compromised by adhesions pulling on the bowel. Most pain specialists try to avoid long-term opioids for adhesion patients specifically because of this double bind. Antispasmodic medications like hyoscine or dicycloverine can sometimes calm the cramping component of adhesion pain, though evidence supporting their use for this specific indication is limited.
Manual and Physical Therapy
One of the more appealing options for adhesion pain is manual therapy, which includes specialized massage, myofascial release, and visceral manipulation techniques performed by trained physiotherapists. The appeal is obvious: it is noninvasive, involves no medication side effects, and can be tried without much risk. A systematic review of manual therapy for post-surgical adhesion symptoms found that these techniques hold potential for managing pain, gastrointestinal symptoms, and musculoskeletal problems related to adhesions, and may serve as a useful complement to conventional medical and surgical treatments.7Journal of Bodywork and Movement Therapies. Impact of manual therapy on adhesion related symptoms post abdominal surgery: A systemic review
Case reports have described patients with partial small bowel obstructions caused by adhesions who experienced sustained symptom resolution after hands-on physical therapy.8PubMed Central. Manual Physical Therapy for Non-Surgical Treatment of Adhesion-Related Small Bowel Obstructions: Two Case Reports The theory is that careful manual pressure and stretching can break down or loosen adhesion bands and restore some normal sliding motion between organs. The evidence is promising but still thin. Most of the supporting data comes from small studies and case series rather than large randomized trials. Still, because the risk is so low, many clinicians now consider a course of specialized physical therapy a reasonable early step, especially for patients with mild to moderate symptoms who want to delay or avoid surgery.
Surgery to Remove Adhesions
Adhesiolysis, the surgical cutting or removal of adhesion bands, is the most direct approach when adhesions are causing severe or persistent symptoms. It is typically done laparoscopically, using small incisions and a camera, to reduce the formation of new adhesions compared with open surgery. Some uncontrolled studies report encouraging results. In one series, about 72 percent of patients reported more than 50 percent pain relief within weeks after laparoscopic adhesiolysis, and roughly two-thirds still reported relief two to five years later.9PubMed Central. Laparoscopic Adhesiolysis and Relief of Chronic Pelvic Pain Another study of women with chronic pelvic pain after hysterectomy found that about half achieved complete pain relief following adhesiolysis, though nearly half of those followed for more than two years required at least one additional surgery.10PubMed. Long-Term Outcome of Laparoscopic Adhesiolysis in Women with Chronic Pelvic Pain after Hysterectomy
The picture gets more complicated when you look at the one landmark randomized controlled trial with long-term follow-up. At twelve years after surgery, patients who had undergone adhesiolysis were actually less often pain-free than those in the placebo group who had a diagnostic laparoscopy only, with no adhesion removal. The adhesiolysis group also used more pain medications and had a higher rate of additional operations over the follow-up period. Both groups did improve in pain and quality-of-life scores over time.11PubMed. Twelve-year outcomes of laparoscopic adhesiolysis in patients with chronic abdominal pain: A randomized clinical trial That trial is sobering and is one of the main reasons adhesiolysis for chronic pain, as opposed to adhesiolysis for clear mechanical problems like bowel obstruction, remains controversial. It suggests that a significant part of the improvement patients experience may come from the placebo effect of surgery itself, from the general tissue handling that occurs during laparoscopy, or from natural changes in pain over time.
The Risks of Adhesiolysis
The paradox of adhesiolysis is that the surgery that removes adhesions often creates new ones. And the surgery itself carries real risks, particularly bowel injury. When a surgeon separates adhesion bands from the bowel wall, the boundary between scar tissue and healthy intestine is not always clean. In one prospective series, about 5 percent of patients undergoing laparoscopic adhesiolysis suffered full-thickness bowel injuries, with half of those needing bowel resection.12PubMed Central. Laparoscopic adhesiolysis: not for all patients, not for all surgeons, not in all centres A broader study found that roughly one in ten patients who required adhesiolysis during abdominal surgery had an inadvertent bowel defect, compared with zero in patients who did not need adhesiolysis.13PubMed. Adhesiolysis-related morbidity in abdominal surgery In the most challenging cases with dense adhesions, the risk of bowel injury has been estimated at 10 to 25 percent, with associated ICU admissions and, in the worst scenarios, a mortality rate around 13 percent.14International Journal of Surgery. Medico-legal consequences of post-operative intra-abdominal adhesions
These numbers do not mean surgery is never the right call. When adhesions cause bowel obstruction, adhesiolysis can be lifesaving. When a patient has severe, well-localized pain with imaging evidence of specific adhesion bands pulling on identifiable structures, targeted adhesiolysis performed by an experienced surgeon can bring genuine relief. The point is that surgery for chronic diffuse adhesion pain, where there is no clear mechanical target, has a weaker risk-benefit profile and needs careful discussion between patient and surgeon.
Nerve Blocks and Neuromodulation
For patients whose adhesion pain has a strong nerve-mediated component, interventional pain procedures offer another avenue. Nerve blocks targeting the sympathetic nervous system or specific ganglia are widely used for refractory visceral pain and can provide substantial, often durable relief, though they carry a small risk of serious adverse events.15PubMed Central. Interventional Pain Procedures: A Narrative Review Focusing on Safety and Complications. Part 3 – Sympathetic and Ganglion-Targeted Techniques In the context of adhesion pain, a celiac plexus block or a superior hypogastric plexus block can interrupt pain signals coming from the abdominal and pelvic organs. These are typically performed under imaging guidance, and their effects can last weeks to months.
Spinal cord stimulation is a more advanced option that has been explored specifically for chronic abdominal pain. A multicenter feasibility study using high-frequency spinal cord stimulation at 10 kHz found that it could provide durable pain relief and improve quality of life in patients with chronic abdominal pain who had not responded to other treatments.16PubMed Central. Treatment of Chronic Abdominal Pain With 10-kHz Spinal Cord Stimulation: Safety and Efficacy Results From a 12-Month Prospective, Multicenter, Feasibility Study The device delivers electrical pulses to the spinal cord through an implanted lead, essentially scrambling pain signals before they reach the brain. It is not a first-line treatment by any stretch, but for people who have exhausted other options and live with debilitating daily pain, neuromodulation is a real and growing option.
Confirming That Adhesions Are the Problem
One reason adhesion pain is so frustrating to treat is that confirming adhesions as the actual source of someone’s symptoms is harder than it sounds. Adhesions do not show up on standard X-rays or CT scans. The most reliable noninvasive method is ultrasound visceral slide assessment, where a sonographer watches in real time to see whether the bowel moves freely beneath the abdominal wall during breathing. A meta-analysis of this technique found it had a sensitivity above 95 percent and a negative predictive value above 99 percent for periumbilical bowel adhesions, meaning a normal result is very good at ruling adhesions out.17PubMed. Ultrasound Visceral Slide Assessment to Evaluate for Intra-abdominal Adhesions in Patients Undergoing Abdominal Surgery – A Systematic Review and Meta-analysis
Cine-MRI, which captures moving images of the abdomen, performs similarly to ultrasound for adhesions to the abdominal wall but appears better at detecting adhesions between organs deeper inside the abdomen.18European Journal of Radiology. Assessment of the diagnostic efficacy of abdominal ultrasonography and cine magnetic resonance imaging in detecting abdominal adhesions: A double-blind research study Neither test is routinely offered at every hospital, and many patients with suspected adhesion pain are never formally imaged for adhesions at all. Getting a proper diagnosis matters because treating adhesion pain is not worthwhile if adhesions are not actually the cause. Abdominal pain after surgery can stem from many things, including nerve entrapment in the scar, irritable bowel syndrome triggered by the surgical insult, or endometriosis in women. Jumping to adhesiolysis without confirming adhesions as the source is one of the more common mistakes in managing these patients.
Putting a Strategy Together
In practice, most clinicians approach adhesion pain in tiers. The first tier is conservative: over-the-counter pain relief, dietary adjustments to reduce bowel distension (smaller meals, avoiding gas-producing foods), gentle exercise, and a trial of manual therapy with a physiotherapist experienced in visceral techniques. If those measures are insufficient, the second tier introduces prescription options like pregabalin or antispasmodics, along with imaging to confirm the diagnosis. Interventional pain procedures such as nerve blocks sit in a middle tier between medication and surgery. Adhesiolysis is generally reserved for patients with clearly identifiable, mechanically significant adhesions causing obstruction or well-localized pain, and even then it is typically discussed with a frank conversation about the possibility that new adhesions will form and that pain may not resolve.
A combination of approaches often works better than any single one. Someone might use pregabalin to bring baseline pain down, attend regular manual therapy sessions to maintain abdominal tissue mobility, and modify their diet to reduce the cramping episodes. That kind of multimodal strategy is common in other chronic pain conditions and makes equal sense here, particularly given the limited evidence supporting any one treatment in isolation.
Therapies on the Horizon
Because adhesion prevention would be the most effective form of pain relief, a good deal of research is focused on stopping adhesions from forming in the first place. Barrier agents, films or gels placed over surgical sites to physically separate healing tissues, have been available for years, but their performance has been inconsistent. The more exciting developments involve targeting the molecular pathways that drive adhesion formation. Researchers have identified a protein called JUN as a key driver of the fibrotic process that creates adhesions.19PubMed Central. Elucidating the fundamental fibrotic processes driving abdominal adhesion formation A preclinical study encapsulated a small-molecule JUN inhibitor in a slow-release hydrogel that could be applied at the surgical site. In animal models, this system was safe, well tolerated, and effective at minimizing both the quantity and the fibrotic density of adhesions without interfering with normal wound healing.20PubMed. Postoperative adhesions are abrogated by a sustained-release anti-JUN therapeutic in preclinical models
Other groups are working on hydrogels loaded with different anti-fibrotic compounds, including one targeting STAT3, another signaling molecule involved in fibroblast proliferation.21PubMed. StatGel: An Innovative hydrogel carrying STAT3-targeted small molecule inhibitor for the treatment of abdominal adhesions A broader scoping review of regenerative medicine approaches for adhesion prevention found that small molecules directed at specific targets in the adhesion pathway could potentially redirect the signaling that leads to scar tissue formation.22PubMed Central. Regenerative Medicine Therapies for Prevention of Abdominal Adhesions: A Scoping Review None of these therapies are available for clinical use yet, and the leap from animal models to human patients is never guaranteed. But the science of adhesion formation has advanced considerably, and the coming decade may bring the first treatments that go beyond managing pain to actually preventing the problem before it starts.
When Adhesion Pain Feels Invisible
One aspect of living with adhesion pain that rarely gets discussed in clinical literature is how isolating the experience can be. Because adhesions are invisible on standard imaging, because there is no blood test that detects them, and because the severity of someone’s pain has no reliable correlation with the number or size of adhesions they have, patients often feel disbelieved. They may see multiple doctors, undergo repeated imaging that comes back normal, and be told their pain is functional or psychological. The discovery that painful adhesions have a distinct molecular and nerve-tissue profile compared with painless adhesions is relatively recent.4PubMed Central. Morphological features and molecular mechanisms in peritoneal adhesions from patients with chronic abdominal postoperative pain It validates what many patients have been saying for years: their pain is real, has a physical basis, and is not proportional to what any scan can see.
Seeking out a clinician who is familiar with adhesion-related pain, ideally a pain specialist or a surgeon experienced in adhesive disease, can make the difference between spinning through the healthcare system and actually landing on a treatment plan that helps. Specialized diagnostic tools like visceral slide ultrasound are underused, and not every gastroenterologist or gynecologist will think to order one. Being your own advocate, asking specifically about adhesions, and requesting appropriate imaging can speed up what is often a slow and frustrating path to diagnosis.